Epigenica
Solna
About Epigenica
Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture and extract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: epigenica.se
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/epigenica-52349 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.